Stocks
Cabaletta Bio, Inc.CABA
NASDAQHealthcareBiotechnology$2.73
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing engineered T cell therapies for autoimmune diseases, with its lead candidate targeting B cell-driven conditions. The company's focus on CAR T cell applications beyond oncology has drawn investor attention as early-stage data in lupus and other indications emerge.
52W Range: $1.73-$4.23
Congressional Interest in Cabaletta Bio, Inc. (CABA)
No congressional trades have been disclosed for Cabaletta Bio, Inc. (CABA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CABA?
No congressional trades found for this stock.